Clinical Trial Update: Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Isa-RVD (isatuximab plus lenalidomide, bortezomib, and dexamethasone) for newly diagnosed multiple myeloma, with status currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)
• SARCLISA (isatuximab)
• Velcade (bortezomib)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING